X
07Jan

DEAL WATCH: End-of-Year Biosimilar Agreements

Goodwin | | Return|
Following the string of biosimilar agreements announced in early November, a number of additional transactions were announced in early December, bringing 2019 to a roaring close with global biosimilars deals. On December 1, 2019, Luye Pharma Group...
By: Goodwin
Source Url: https://www.jdsupra.com/legalnews/deal-watch-end-of-year-biosimilar-10061/

Related

401(k) Plan Participant Cannot Pursue Claims On Behalf Of Plans In Which She Did Not Participate

A federal district court in Ohio concluded that a 401(k) plan participant could assert fiduciary bre...

Read More >

Canada: Massive Overhaul of the Canada Labour Code Pending

A massive overhaul of the Canada Labour Code (CLC) is pending, with significant amendments coming in...

Read More >

#10YearChallenge: How Much of a Difference Has a Decade Made in Employment Law?

Early in 2019, social media feeds, from Instagram to Twitter and Facebook, were filled with “10-Yea...

Read More >

D.C. Circuit Rejects “Academic Deference” Argument In Tenure Denial Discrimination Cases

On June 14, 2019, the United States Court of Appeals for the District of Columbia Circuit rejected t...

Read More >

Massachusetts Paid Family and Medical Leave: The Final Regulations and Related Tax Considerations

After a three-month delay in implementation to prepare for compliance, employer deductions under the...

Read More >

New York State Legislature Enacts Sweeping Changes to Combat Sexual Harassment

On June 19th, the New York State Senate and Assembly voted to pass omnibus legislation greatly stren...

Read More >